Search research articles
Contact Us
Filters
Showing results (751-760 of 816) with videos related to
Page
of 82
Sort By:
The New England Journal of Medicine
|
April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemia
Martin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
Brain : a Journal of Neurology
|
September 17, 2015
Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease
Andreia Teixeira-Castro, Ana Jalles, Sofia Esteves, et al.
The Lancet. Oncology
|
June 15, 2016
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus
Kjeld Schmiegelow, Andishe Attarbaschi, Shlomit Barzilai, et al.
Blood
|
December 17, 2009
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia
Lewis B Silverman, Jeffrey G Supko, Kristen E Stevenson, et al.
Leukemia
|
February 21, 2014
Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia
C Reynolds, J E Roderick, J L LaBelle, et al.
The American Journal of Gastroenterology
|
January 13, 2006
Risk factors for post-ERCP pancreatitis: a prospective multicenter study
Chi-Liang Cheng, Stuart Sherman, James L Watkins, et al.
Pediatric Blood & Cancer
|
November 2, 2017
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001
Justine M Kahn, Peter D Cole, Traci M Blonquist, et al.
Pediatric Blood & Cancer
|
March 22, 2022
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001
Uma H Athale, Yael Flamand, Traci Blonquist, et al.
Haematologica
|
February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)
Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
British Journal of Haematology
|
December 25, 2025
Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge
Adriana Balduzzi, Maria Grazia Valsecchi, Thai Hoa Tran, et al.
Page
of 82
Search research articles
Search
Showing results (751-760 of 816) with videos related to
Sort By:
Page
of 82
The New England Journal of Medicine
|
April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemia
Martin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
Brain : a Journal of Neurology
|
September 17, 2015
Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease
Andreia Teixeira-Castro, Ana Jalles, Sofia Esteves, et al.
The Lancet. Oncology
|
June 15, 2016
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus
Kjeld Schmiegelow, Andishe Attarbaschi, Shlomit Barzilai, et al.
Blood
|
December 17, 2009
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia
Lewis B Silverman, Jeffrey G Supko, Kristen E Stevenson, et al.
Leukemia
|
February 21, 2014
Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia
C Reynolds, J E Roderick, J L LaBelle, et al.
The American Journal of Gastroenterology
|
January 13, 2006
Risk factors for post-ERCP pancreatitis: a prospective multicenter study
Chi-Liang Cheng, Stuart Sherman, James L Watkins, et al.
Pediatric Blood & Cancer
|
November 2, 2017
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001
Justine M Kahn, Peter D Cole, Traci M Blonquist, et al.
Pediatric Blood & Cancer
|
March 22, 2022
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001
Uma H Athale, Yael Flamand, Traci Blonquist, et al.
Haematologica
|
February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)
Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
British Journal of Haematology
|
December 25, 2025
Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge
Adriana Balduzzi, Maria Grazia Valsecchi, Thai Hoa Tran, et al.
Page
of 82